The efficacy of MAT to reduce opiate withdrawal, curb cravings, and support positive health, behavioral health, and criminal justice outcomes, including reductions is overdose deaths and recidivism, has gained national attention from criminal justice advocacy groups and policymakers. Jails and correctional agencies have been taken to court over the provision of MAT for incarcerated individuals with OUD. And state and federal courts have ruled denial of MAT for incarcerated individuals with OUD violates the Americans with Disabilities Act (ADA) (Legislative Analysis and Public Policy Association (LAPPA), n.d.).
Notice:
The National Institute of Corrections is currently assessing its website and materials in accordance with recent Executive Orders and related guidance. During this review, some of NIC’s webpages and publications may be temporarily unavailable. Please revisit this web page for updates.
A Review of Medication-Assisted Treatment (MAT) in United States Jails and Prisons
Notice about external resources
These links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by the National Institute of Corrections (NIC) of any of the products, services or opinions of the corporation or organization or individual. NIC bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content.
- Created:Updated: